New Pentagon policy reinstates mandatory testosterone deficiency screenings for male service members over 30, reversing a recent pause in testing protocols. The updated guidance aims to standardize screening and treatment protocols through the Defense Health Agency, ensuring consistent care for affected personnel. The move follows concerns over undiagnosed cases and varying medical approaches across military health systems. Details on implementation and potential impacts on military readiness remain under review.
The Pentagon issued new guidance late Thursday instructing mandatory testosterone deficiency screening for male active-duty and reserve service members over the age of 30 after temporarily rescinding previous guidance earlier this month. The department said the updated guidance will address male testosterone deficiency and establish uniform screening and treatment pathways across the Defense Health Agency...
